QuantCapitol. Congressional Trading Intelligence

Updated 2026-11-05 17:03 UTC · Public disclosure record

CRTICKER

Crane Co.

BULLISH stock

Congress has disclosed 7 buys and 5 sells of CR (Crane Co.) in official financial disclosures, each linked to its original filing. A transparency record — not investment advice.

Activity Congressional Activity

7
Buy
5
Sell
+2
Net
3
Active politicians
Price & congressional trades
Buy Sell

Fundamentals · FY2026 Valuation

Standard valuation multiples from SEC-reported GAAP financials (trailing twelve months), each compared to the median for —. We use reported GAAP, not forward or adjusted earnings, so our figures can sit higher than sites that do — especially for companies with falling profit. Relative context — not a target price or investment advice.

P/E
33.49
no sector median
how it's calculated
P/E = price ÷ earnings per share
$198.02 ÷ $5.91 = 33.49
Based on GAAP trailing-twelve-month financials (SEC filings) and the latest close. Other sites may show a different multiple when they use forward (projected) or non-GAAP adjusted figures instead of reported GAAP — for a company with volatile profit those can differ in either direction from the GAAP figure shown here.
P/B
5.05
no sector median
how it's calculated
P/B = price ÷ book value per share
$198.02 ÷ $39.19 = 5.05
Based on GAAP trailing-twelve-month financials (SEC filings) and the latest close. Other sites may show a different multiple when they use forward (projected) or non-GAAP adjusted figures instead of reported GAAP — for a company with volatile profit those can differ in either direction from the GAAP figure shown here.
EV/EBITDA
22.52
no sector median
how it's calculated
EV/EBITDA = (market cap + net debt) ÷ EBITDA
($11.5B + $0.6B net debt) ÷ $0.5B = $12.1B ÷ $0.5B = 22.52
Based on GAAP trailing-twelve-month financials (SEC filings) and the latest close. Other sites may show a different multiple when they use forward (projected) or non-GAAP adjusted figures instead of reported GAAP — for a company with volatile profit those can differ in either direction from the GAAP figure shown here.

12 trades Recent Congressional Trades

Two things to watch per trade: the disclosure lag (how many days passed before the trade was made public) and the price move in that window (how the stock moved during those non-public days). A sell followed by a price drop, or a buy followed by a rise, means well-timed trading — visible here in the open. Note: the Score measures how notable a trade is, not whether it made money — the price move is shown for context and isn't part of it.

PoliticianChamberTypeOwnerDateDisclosure lagPrice move
in that
window
AmountScoreSource
Kevin Hern House SELL ◆ insider convergence Joint · Hern Family Foundation 2026-08-31 15 days -4.7% $50K–$100K
0.9% of NW
65.3 ↗ filing
Kevin Hern House SELL Joint · Kevin Hern Insurance Trust 2022-11-21 1 days — $1K–$15K
0.1% of NW
15.7 ↗ filing
Kevin Hern House BUY Joint 2021-11-26 1 days — $15K–$50K
0.4% of NW
48.0 ↗ filing
Kevin Hern House BUY Joint 2020-07-27 1 days — $1K–$15K
0.1% of NW
40.4 ↗ filing
Kevin Hern House BUY Joint 2019-10-15 0 days — $1K–$15K
0.1% of NW
75.9 ↗ filing
Nicholas Taylor House SELL Spouse 2019-03-25 0 days — $1K–$15K 75.9 ↗ filing
Thomas MacArthur House SELL Joint 2018-10-09 23 days — $1K–$15K 8.6 ↗ filing
Thomas MacArthur House SELL Joint 2018-05-11 21 days — $1K–$15K 10.6 ↗ filing
Thomas MacArthur House BUY Joint 2017-12-19 13 days — $15K–$50K 48.0 ↗ filing
Thomas MacArthur House BUY Child 2017-12-19 13 days — $1K–$15K 22.3 ↗ filing
Thomas MacArthur House BUY Child 2017-07-28 4 days — $1K–$15K 75.9 ↗ filing
Thomas MacArthur House BUY Joint 2017-07-28 4 days — $50K–$100K 94.3 ↗ filing

Corporate insiders · SEC Form 4 Insider Activity

What the company's own officers and directors did in CR — open-market purchases and sales from SEC Form 4 filings (option exercises, grants and tax withholding are excluded). This is context for the congressional activity above, never a buy/sell signal, and the two datasets are kept separate on purpose. Does convergence mean anything? →

1
Congress trades with insider convergence
0
…with insider divergence
35
Insider open-market trades

Of the congressional trades in CR, 1 coincided with corporate insiders moving the same way within 60 days, and 0 with insiders moving the opposite way. This is co-occurrence only — whether it carries any edge is tested honestly on the convergence page.

DateInsiderRoleTypeSizeSource
2026-08-31 TULLIS JAMES L L Director SELL $82K ↗ EDGAR
2026-08-13 TULLIS JAMES L L Director SELL $138K ↗ EDGAR
2026-04-30 Lynch Susan D Director BUY $27K ↗ EDGAR
2026-02-13 Feldman Jason D. Other SELL $544K ↗ EDGAR
2026-01-30 MITCHELL MAX H C-suite BUY $184K ↗ EDGAR
2026-01-29 Kapoor Sanjay Director BUY $500K ↗ EDGAR
2026-01-29 Lynch Susan D Director BUY $18K ↗ EDGAR
2026-01-29 Lynch Susan D Director BUY $9K ↗ EDGAR
2026-01-29 Pollino Jennifer Director BUY $276K ↗ EDGAR
2025-08-25 Alcala Alejandro C-suite SELL $3.0M ↗ EDGAR
2025-08-25 Alcala Alejandro C-suite SELL $928K ↗ EDGAR
2025-08-25 Alcala Alejandro C-suite SELL $123K ↗ EDGAR
2025-08-21 Maue Richard A C-suite SELL $1.1M ↗ EDGAR
2025-08-21 Maue Richard A C-suite SELL $532K ↗ EDGAR
2025-08-20 Maue Richard A C-suite SELL $2.6M ↗ EDGAR
2025-08-20 Maue Richard A C-suite SELL $1.3M ↗ EDGAR
2025-05-20 Feldman Jason D. Other SELL $230K ↗ EDGAR
2025-02-06 Alcala Alejandro C-suite SELL $392K ↗ EDGAR
2024-02-29 D'Iorio Anthony M. Other SELL $455K ↗ EDGAR
2024-02-29 D'Iorio Anthony M. Other SELL $162K ↗ EDGAR
2023-11-29 MITCHELL MAX H C-suite SELL $442K ↗ EDGAR
2023-11-28 MITCHELL MAX H C-suite SELL $1.2M ↗ EDGAR
2023-11-28 MITCHELL MAX H C-suite SELL $184K ↗ EDGAR
2023-11-28 MITCHELL MAX H C-suite SELL $143K ↗ EDGAR
2023-11-28 MITCHELL MAX H C-suite SELL $63K ↗ EDGAR

Combined timeline — Congress & insiders

Both sets of trades on one timeline, newest first, so you can see when they lined up. Congress vs ◆ insider.

DateWhoTypeSize
Congress 2026-08-31 Kevin Hern SELL $50K–$100K
◆ insider 2026-08-31 TULLIS JAMES L L Director SELL $82K
◆ insider 2026-08-13 TULLIS JAMES L L Director SELL $138K
◆ insider 2026-04-30 Lynch Susan D Director BUY $27K
◆ insider 2026-02-13 Feldman Jason D. Other SELL $544K
◆ insider 2026-01-30 MITCHELL MAX H C-suite BUY $184K
◆ insider 2026-01-29 Kapoor Sanjay Director BUY $500K
◆ insider 2026-01-29 Lynch Susan D Director BUY $18K
◆ insider 2026-01-29 Lynch Susan D Director BUY $9K
◆ insider 2026-01-29 Pollino Jennifer Director BUY $276K
◆ insider 2025-08-25 Alcala Alejandro C-suite SELL $3.0M
◆ insider 2025-08-25 Alcala Alejandro C-suite SELL $928K
◆ insider 2025-08-25 Alcala Alejandro C-suite SELL $123K
◆ insider 2025-08-21 Maue Richard A C-suite SELL $1.1M
◆ insider 2025-08-21 Maue Richard A C-suite SELL $532K
◆ insider 2025-08-20 Maue Richard A C-suite SELL $2.6M
◆ insider 2025-08-20 Maue Richard A C-suite SELL $1.3M
◆ insider 2025-05-20 Feldman Jason D. Other SELL $230K
◆ insider 2025-02-06 Alcala Alejandro C-suite SELL $392K
◆ insider 2024-02-29 D'Iorio Anthony M. Other SELL $455K
◆ insider 2024-02-29 D'Iorio Anthony M. Other SELL $162K
◆ insider 2023-11-29 MITCHELL MAX H C-suite SELL $442K
◆ insider 2023-11-28 MITCHELL MAX H C-suite SELL $1.2M
◆ insider 2023-11-28 MITCHELL MAX H C-suite SELL $184K

FAQ Common questions

How much has Congress traded CR?

7 disclosed buys and 5 sells of CR (Crane Co.) appear in official congressional financial disclosures.

Is it legal for members of Congress to trade CR?

Members of Congress may trade stocks but must disclose it under the STOCK Act. QuantCapitol tracks those public disclosures for transparency — nothing here is an accusation of wrongdoing or investment advice.

Where does this data come from?

Official US House Clerk and Senate electronic financial disclosures. Every trade links back to its original filing so you can verify it yourself.

About this data. Sourced from official House Clerk and Senate eFD financial disclosures (Senate via a maintained community mirror — see project documentation). Transaction amounts are reported as ranges, not exact figures. Interest scores, consensus labels, and backtested performance are proprietary analytical calculations based on public data and are not investment advice. Backtested performance is a hypothetical simulation, not actual portfolio performance.